PHARMAGEST INTERACTIVE : ANNUAL ORDINARY GENERAL MEETING ON JUNE 27, 2017 Notice


Villers-lès-Nancy, June 12, 2017 - 18h30 (CET)
PRESS RELEASE
 
 
ANNUAL ORDINARY GENERAL MEETING ON JUNE 27, 2017
 
Notice
 
The shareholders of PHARMAGEST INTERACTIVE are invited to attend the Annual Ordinary General Meeting that will be held on Tuesday, June 27, 2017 at 5.00 pm, at headquarters located in VILLERS-LES-NANCY (54600), 5 allée de Saint Cloud.
 
The agenda and the draft resolutions were published in the BALO (Bulletin des Annonces Légales et Obligatoires)  of May 19, 2017 (www.journal-officiel.gouv.fr).
 
The present notice of meeting was published in the BALO of June 9, 2017, in the Official Journal "Tablettes Lorraines" of June 12, 2017, and on the company's website (www.pharmagest.com / Finance).
 
Shareholders will be able to obtain the documents with regard to this Shareholders' Meeting on request from the company's registered office in VILLERS-LES-NANCY (54600).
 
About PHARMAGEST Group:
 
PHARMAGEST Group is the French pharmacy information technology leader, with a 43.5% market share and more than 900 employees. The Group's strategy is based on a core business, information technology innovation to improve health care, and on the development of two priorities: 1/ Services and technologies for healthcare professionals, with a focus on assisting pharmacies in the area of patient medication compliance; and 2/ technologies for improving the efficacy of healthcare systems.
To roll out that strategy, PHARMAGEST Group has developed specialised businesses, including pharmacy IT, e-Health solutions, solutions for healthcare professionals, solutions for pharmaceutical laboratories, connected health devices and apps, and a sales financing marketplace.
These businesses are now divided into four divisions: The Solutions for Pharmacy Division - Europe, the Solutions for Health and Medical-Social Institutions Division, the Solutions for e-Health Division, and the Fintech Division.
 
Listed on Euronext Paris(TM) - Compartment B
Indices: CAC® SMALL and CAC® All-Tradable par inclusion Eligible for the Long-Only Deferred Settlement Service (SRD)
ISIN: FR 0012882389 - Reuters: PHA.PA - Bloomberg: - PMGI FP
 
For all the latest news go to www.pharmagest.com
 
CONTACTS
Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves SAMSON Tel. +33 (0)3 83 15 90 67 - jean-yves.samson@pharmagest.com
Media Relations:
FIN'EXTENSO - Isabelle APRILE
Tel. +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr

Attachments

PHARMAGEST INTERACTIVE : ANNUAL ORDINARY GENERAL MEETING ON JUNE 27, 2